|Videos|December 22, 2022
Depression and Comorbid Health Conditions
Carmen Kosicek, MSN, PMHNP-BC, and Charles Montano, MD, comment on the interplay between depression and other comorbid psychiatric and medical health conditions as well as the economic impact of MDD.
Advertisement
Episodes in this series
Advertisement
Related to this article
FDA awarded DT120 Breakthrough Therapy designation for MDD based on phase 3 data showing rapid, sustained improvement after one 100 μg dose.
Advertisement
Advertisement
Trending on Patient Care Online
1
Who Should Get a CGM? Expanding the Primary Care Candidate Pool
2
FDA Grants Breakthrough Device Designation to Natera's Multi-Cancer Early Detection Blood Test
3
Updated Freenome CRC Blood Test Detects 18.2% of Advanced Precancerous Lesions
4
Most Adolescents With Colorectal Cancer Diagnosed at Advanced Stage, Study Finds
5